These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 788925)

  • 1. Antigen responsiveness of an established human B-lymphoid cell line. I. Evidence for a surface receptor for Candida antigen detected by direct migration inhibition.
    Baskin BL; Meltz SK; Glade PR
    Cell Immunol; 1976 Oct; 26(2):264-73. PubMed ID: 788925
    [No Abstract]   [Full Text] [Related]  

  • 2. Antigen responsiveness of an established human B-lymphoid cell line. II. Loss of Candida antigen responsiveness following exposure of cells to specific anti-human immunoglobulin antisera.
    Baskin BL; Meltz SK; Glade PR
    Cell Immunol; 1976 Oct; 26(2):274-83. PubMed ID: 824057
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of leukocyte migration by the agarose plate technique. Application to antigen from Candida albicans and Fusobacterium nucleatum.
    Budtz-Jorgensen E
    Acta Allergol; 1977 Feb; 32(1):15-26. PubMed ID: 320806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The adjuvant and specific activity of transfer factors to Candida albicans antigens].
    Borysov VA; Cheusova ZV; Molozhava OS
    Fiziol Zh (1994); 1998; 44(4):3-9. PubMed ID: 9669168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct activation of human B lymphocytes by Candida albicans-derived mannan antigen.
    Mangeney M; Fischer A; Le Deist F; Latgé JP; Durandy A
    Cell Immunol; 1989 Sep; 122(2):329-37. PubMed ID: 2475258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A further characterization of Candida albicans-induced suppressor B-cell activity.
    Cuff CF; Packer BJ; Rogers TJ
    Immunology; 1989 Sep; 68(1):80-6. PubMed ID: 2530158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presentation of Candida albicans and purified protein derivative soluble antigens by Epstein-Barr virus-transformed human lymphoblastoid B-cell lines.
    Reitnauer PJ; Brown LR; Hank JA; Sondel PM
    Cell Immunol; 1986 Apr; 99(1):196-208. PubMed ID: 3019572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Responses of T and B lymphocytes to a Paracoccidioides brasiliensis cell wall extract in healthy sensitized and nonsensitized subjects.
    Benard G; Durandy A; Assis CM; Hong MA; Orii NM; Sato MN; Mendes-Gianini MJ; Lacaz CS; Duarte AJ
    Am J Trop Med Hyg; 1995 Aug; 53(2):189-94. PubMed ID: 7677223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against rat vaginal candidiasis by adoptive transfer of vaginal B lymphocytes.
    De Bernardis F; Santoni G; Boccanera M; Lucciarini R; Arancia S; Sandini S; Amantini C; Cassone A
    FEMS Yeast Res; 2010 Jun; 10(4):432-40. PubMed ID: 20402794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candida and AIDS: evidence for protective antibody.
    Matthews R; Burnie J; Smith D; Clark I; Midgley J; Conolly M; Gazzard B
    Lancet; 1988 Jul; 2(8605):263-6. PubMed ID: 2899245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cell electrophoretic studies in candida mycoses].
    Kaben U; Jenssen HL; Köhler H; Westphal HJ; Mix E
    Dermatol Monatsschr; 1976 Feb; 162(2):117-20. PubMed ID: 782938
    [No Abstract]   [Full Text] [Related]  

  • 12. Phagocytosis of heat-killed blastospores of Candida albicans by human monocyte beta-glucan receptors.
    Janusz MJ; Austen KF; Czop JK
    Immunology; 1988 Oct; 65(2):181-5. PubMed ID: 2847978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nature of the cells regulating the production of a migration inhibition factor in C57BL/6 strain mice with low response to Candida albicans antigen].
    Vorob'ev KV; Koval'chuk LV; Gankovskaia LV
    Biull Eksp Biol Med; 1984 Nov; 98(11):601-2. PubMed ID: 6239664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between HLA-D and in vitro and in vivo responsiveness to Candida allergen.
    Nose Y; Komori K; Inouye H; Nomura K; Yamamura M; Tsuji K
    Clin Exp Immunol; 1980 May; 40(2):345-50. PubMed ID: 7002388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous IgG (IVIG) and subcutaneous IgG (SCIG) preparations have comparable inhibitory effect on T cell activation, which is not dependent on IgG sialylation, monocytes or B cells.
    Issekutz AC; Rowter D; Miescher S; Käsermann F
    Clin Immunol; 2015 Oct; 160(2):123-32. PubMed ID: 25982320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interstrain differences in mice in developing migration inhibition factors to Candida albicans antigens].
    Vorob'ev KV; Gankovskaia LV; Koval'chuk LV; Shabanova LF
    Biull Eksp Biol Med; 1983 Oct; 96(10):80-2. PubMed ID: 6354302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B- and T-cell markers on human lymphoblasts after stimulation with mitogen or antigens.
    Kreeftenberg JG; Leerling MF; Loggen HG
    Clin Exp Immunol; 1975 Oct; 22(1):121-5. PubMed ID: 765017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on stimulation of cell-mediated cytotoxicity by skin test antigens. I. Candida antigen stimulation of cell-mediated cytotoxicity in vitro correlated with the skin test response to candida antigen in vivo.
    Tartof D; Check IJ; Matutis A; Hunter RL; Fitch FW
    J Immunol; 1980 Dec; 125(6):2790-6. PubMed ID: 6159422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune responsiveness of a novel peptidoglycan conjugate prepared from surface Candida immunogens: mannan and CR3-related protein.
    Paulovicová E; Bystrický S; Machová E; Bujdáková H
    FEMS Immunol Med Microbiol; 2008 Aug; 53(3):421-8. PubMed ID: 18625018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B cell-independent selection of memory T cells after mucosal immunization with Candida albicans.
    Jones-Carson J; Vazquez-Torres FA; Balish E
    J Immunol; 1997 May; 158(9):4328-35. PubMed ID: 9126995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.